News | March 15, 2026
China’s NMPA approves Zydus-licensed anaemia drug Desidustat
Desidustat tablets are a novel oral HIF-PHI approved for treating anaemia in non-dialysis adult CKD patients
Desidustat tablets are a novel oral HIF-PHI approved for treating anaemia in non-dialysis adult CKD patients
Lilly has long voiced concerns over mass-compounded knockoffs of its tirzepatide medicines, Mounjaro and Zepbound
The move comes as China rapidly expands its capabilities in the pharmaceutical sector, particularly in licensing and drug development
One task, one interaction, one pair, experts advocate
The move comes as the global biotech and biopharma CDMO market continues to surge, fueled by rising demand
The initiative provides clearer regulatory guidance and a defined path from research in space to patient access on Earth
Under the deal, Hims & Hers will offer patients access to FDA-approved versions of Ozempic and Wegovy at the same self-pay prices available through other telehealth platforms
Huwel’s diagnostic solutions leverage open RT-PCR system
ShunzymeX leverages a proprietary protease to streamline purification
The inspection concluded with zero observations, confirming the facility's compliance with current Good Manufacturing Practices
Subscribe To Our Newsletter & Stay Updated
